Should You Be Able to Patent an Organism?
By Robert Hart,
Slate
| 04. 07. 2017
As with many new fields, synthetic biology—which incorporates disparate disciplines like engineering, computer science, biotechnology, and molecular biology—is hard to pin down. But a rough working definition says that it is the application of the principles of engineering to biological systems. Instead of using engineering’s discrete modules of code, transistors, resistors, and capacitors, synthetic biology builds things from sequences of genetic material. The field has remarkable potential and has already been used to aid the production of antimalarial drugs and synthetic flavorings. One researcher used mail-order DNA and a genetic map available online for free to create a live polio virus. The implications could be enormous.
But the same characteristics that make it promising also create profound questions, particularly in terms of who will profit. Can you own or patent synthetic organisms? How will researchers access the genetic materials needed to do research? Will big companies be able to dictate who can participate in research? How we answer these questions and others will shape the future of the field—and determine whether synthetic biology lives up to its touted...
Related Articles
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
By Gemma Conroy, Nature | 06.27.2024
Image by Robina Weermeijer from Unsplash
A molecular-editing tool that’s small enough to be delivered to the brain shuts down the production of proteins that cause prion diseases, a rare but deadly group of neurodegenerative disorders.
The system — known...
By Julia Black and Margaux MacColl, The Information [cites CGS' Katie Hasson] | 07.19.2024
When venture capitalist Jack Abraham first began dating his wife, Gabriella Massamillo, he insisted on one condition: that when they were ready to have children, she’d be willing to conceive using in vitro fertilization. Abraham had lost both his mother...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...